首页> 外文期刊>Oncology: International Journal of Cancer Research and Treatment >Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in France
【24h】

Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in France

机译:40岁以下患者肺癌的特征:法国的前瞻性多中心分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: The aim of this study was to describe the demographic and clinico-pathological characteristics of lung cancer in patients younger than 40 years. Materials and Methods: This was a prospective study performed within the Groupe Francais de Pneumo-Cancerologie. Consecutive patients diagnosed with lung cancer before the age of 40 years were eligible. Data on demographics, medical history, clinico-pathological characteristics, treatment and overall survival were analysed. Results: In total, 146 patients were included from January 2011 to December 2013. Median age was 38 years (IQR: 34-40). Women accounted for 41%. Main histological type was adenocarcinoma (77%). Only 3% had a prior history of cancer, but a family history (first-or second-degree relatives) of cancer was reported in 80 (55%) patients; 85 and 50% were current or past smokers of tobacco and cannabis, respectively; 82% had stage IIIB/IV at diagnosis. Median overall survival was 15.3 (95% CI: 8.1-24.0) months in the whole population, 10.3 (95% CI: 12.5-14.2) months in stage IV and 15 (95% CI: 8.7-35.2) months in stage III. One-and two-year overall survival rates were 57% (95 CI: 49-65) and 31.5% (95 CI: 27-43), respectively. Compared to smokers, non-smokers were significantly younger and more often females. Median overall survival was not statistically different between smokers and non-smokers. (C) 2018 S. Karger AG, Basel
机译:目的:本研究的目的是描述40岁以下肺癌的人口统计和临床病理特征。材料和方法:这是在Grane Francais de Pneumo-cancerologie内进行的前瞻性研究。在40岁之前被诊断患有肺癌的连续患者有资格。分析了有关人口统计学,病史,临床病理特征,治疗和整体存活的数据。结果:总共有146名患者于2011年1月至2013年12月。中位年龄为38岁(IQR:34-40)。女性占41%。主要组织学型是腺癌(77%)。只有3%的癌症历史历史,但80例(55%)患者报告了癌症的家族史(第一或二级亲属); 85和50%分别是烟草和大麻的目前或过去的吸烟者; 82%在诊断时进行IIIB / IV阶段。中位数全身生存率为15.3(95%CI:8.1-24.0)个月,阶段IV阶段10.3(95%CI:12.5-14.2)月,第三阶段,15(95%CI:8.7-35.2)。一年和两年的总生存率分别为57%(95ci:49-65)和31.5%(95ci:27-43)。与吸烟者相比,非吸烟者显着更年轻,女性更频繁。吸烟者和非吸烟者之间的中位数整体生存并不统计学。 (c)2018年S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号